• Supporting researchers in setting up research projects
• Managing research collaborations between the university and its external partners (industry and public institutions)
• Transferring R&D technology (patents, spin-offs, etc.)
• Managing the ULB’s Intellectual Property (IP)
• Supporting R&D projects
• Contributing to local and regional economic growth
Overview
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 19, 2024 | InSphero, Breakthrough T1D and Université libre de Bruxelles Collaborate to Find New Cures for Type 1 Diabetes | InSphero, Breakthrough T1D, and Université Libre de Bruxelles Collaborate to Find New Cures for Type 1 Diabetes InSphero, Breakthrough T1D, and ULB partner to discover novel T1D treatments, aiming to protect and preserve vital insulin-produ... |
| May 20, 2024 | Syngulon and ULB announce the issuance by the USPTO of a first joint patent covering an antibiotic-free selection technology | Syngulon and ULB announce the issuance by the USPTO on March 19, 2024 of US Patent 11,932,672 covering an antibiotic-free selection technology based on bacteriocin/immunity for the production of recombinant protein or pDNA. SERAING, Belgium... |
Reviews 0
FAQ about ULB Technology Transfer Office (ULB-TTO)
When was ULB Technology Transfer Office (ULB-TTO) founded?
ULB Technology Transfer Office (ULB-TTO) was founded in 1991.
What has the press written about ULB Technology Transfer Office (ULB-TTO)?
Parsers VC has collected 3 articles mentioning ULB Technology Transfer Office (ULB-TTO), among them “InSphero, Breakthrough T1D and Université libre de Bruxelles Collaborate to Find New Cures for Type 1 Diabetes” (Aug 19, 2024) and “Syngulon and ULB announce the issuance by the USPTO of a first joint patent covering an antibiotic-free selection technology” (May 20, 2024).
Is ULB Technology Transfer Office (ULB-TTO) still active?
Yes, ULB Technology Transfer Office (ULB-TTO) is active; its latest activity on Parsers VC dates from Sep 17, 2024.